Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 5 oxo-5,8-dihydropyrido[2,3-d]pyrimidine derivatives as CaMKII kinase inhibitors for treating cardiovascular diseases

5 oxo-5,8-dihydropyrido[2,3-d]pyrimidine derivatives as CaMKII kinase inhibitors for treating cardiovascular diseases

US Patent 8975250 · Granted Mar 10, 2015

Estimated economic value: $34,000,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Modified lipidated relaxin B chain peptides and their therapeutic use2023
Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their prepa2022
Substituted N-(3-fluoropropyl)-pyrrolidine compounds, processes for their prepar2021
Modified lipidated Relaxin B chain peptides and their therapeutic use2021
Modified relaxin B chain peptides and their therapeutic use2021
Thienopyrimidine derivatives, processes for the preparation thereof and therapeu2021
Modified lipidated Relaxin B chain peptides and their therapeutic use2021
Thienopyrimidine derivatives, processes for the preparation thereof and therapeu2020
Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their prepa2020
Thienopyrimidine derivatives, processes for the preparation thereof and therapeu2019
Thienopyrimidine derivatives, processes for the preparation thereof and therapeu2019
Therapeutic uses of novel thienopyrimidine derivatives2017